跳至主要内容
临床试验/NCT05900232
NCT05900232招募中不适用

Anti KU Antibodies and Its Relationship With Systemic Lupus Erythematosus

Sohag University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年5月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
1
主要终点
Anti KU antibodies and its relationship with Systemic Lupus Erythematosus manifestations

研究概览

简要总结

systemic lupus Erythematosus (SLE) is a multi system autoimmune disorder abroad spectrum of clinical presentations.

Diagnosis of SLE depending on Systemic Lupus International Collaborating Clinics (SLICC) Criteria.

SLICC Criteria requires either that a patient satisfy at least 4 of 17 Criteria including at least 1 of 11 clinical criteria and 1 of 6 immunological criteria or the patient has biopsy -proven nephritis compatible with SLE in the presence of antinuclear antibodies (ANA)or anti_double stranded DNA (dsDNA) antibodies.

Anti_KU antibodies included in (ANA), reported in many autoimmune disorders like SLE,Sjogren syndrome, idiopathic lung fibrosis and myositis.

So the aim of the work is to determine the relationship between Anti_KU antibodies and SLE manifestations.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
17 Years 至 60 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • all patients will fulfill the Systemic Lupus International Clinics(SLICC) classification criteria for Systemic Lupus Erythematosus.

排除标准

  • any patient with any collagen disease other than SLE

结局指标

主要结局

Anti KU antibodies and its relationship with Systemic Lupus Erythematosus manifestations

时间窗: 6 months

the study will evaluate the titre of Anti KU antibodies which is positive or negative in one patient and on the other side what is the manifestation of SLE that found in the same patient if the Anti KU Antibodies titre is positive

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nehal Abdelbasset Ahmed

Resident Doctor at Rheumatology Department

Sohag University

研究点 (1)

Loading locations...

相似试验